NRGSX | STSRX | NRGSX / STSRX | |
Total Expense Ratio | 0.74 | 0.97 | 76% |
Annual Report Gross Expense Ratio | 0.74 | 1.05 | 70% |
Fund Existence | 13 years | 6 years | - |
Gain YTD | -4.285 | 13.579 | -32% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.69B | 455M | 1,909% |
Annual Yield % from dividends | 0.06 | 0.00 | - |
Returns for 1 year | -10.47 | 6.26 | -167% |
Returns for 3 years | 5.48 | 29.62 | 19% |
Returns for 5 years | -2.71 | -7.31 | 37% |
Returns for 10 years | 9.80 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CLBAX | 38.93 | 0.05 | +0.13% |
American Funds American Balanced 529A | |||
CCERX | 29.79 | N/A | N/A |
Columbia Large Cap Enhanced Core R | |||
RYVYX | 691.86 | N/A | N/A |
Rydex NASDAQ-100® 2x Strategy H | |||
FCVIX | 19.90 | N/A | N/A |
Fidelity Advisor Small Cap Value I | |||
GMVAX | 16.43 | N/A | N/A |
Goldman Sachs Small/Mid Cap Equity A |